The Healthcare System of the Future: Emerging Technologies that Enable Drug Development and Patient Treatment

2:15 PM - 3:15 PM (EDT), Monday, June 5, 2023 ・ Session Room 208
Novel enabling technologies (ET) and therapies emerge at an ever-increasing speed across multiple domains related to drug development. These innovations are arising from academic and public researchers, classic pharmaceutical development companies, and increasingly, solution providers, device developers and a range of consortia. These diverse stakeholders are increasingly approaching authorities for interactions and advice on how to develop and successfully market them.

This session will provide an overview of recent and upcoming enabling technologies (ET) relevant to drug development. Examples provided will demonstrate opportunities on how to maximize the benefit of ET for healthcare solutions.
Head of Innovation and Development Accelerator (IDeA)
European Medicines Agency (EMA)
Head of Unit EIC Accelerator
European Innovation Council and SMEs Agency (EISMEA)
Head of Sector for Health Industry
European Commission’s Directorate General for Research and Innovation
Innovation Procurement Advisor
European Innovation Council and SMEs Agency (EISMEA)
Regulatory Shaping Lead , Integrated Solutions & Regulatory Policy Lead, Digital Health